Cargando…
Utilization Patterns of Coagulation Factor Consumption for Patients with Hemophilia
Hemophilia is a serious rare disease that requires continuous management and treatment for which the medicine is costly at the annual average of 100 million KRW for an individual. The aim of this study was to investigate trends in the utilization of coagulation factor (CF) used for hemophilia treatm...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712577/ https://www.ncbi.nlm.nih.gov/pubmed/26770035 http://dx.doi.org/10.3346/jkms.2016.31.1.33 |